Tender Details

Country: Canada
Summary: Vaccinia Immune Globulin (Vig) (6D024-214840/A)
CAT Ref No: 60926009
Deadline: 23 Dec 2021
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 6D024-214840/A
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Tender are invited for Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UKTendering Procedures: Generally only one firm has been invited to bidNon-Competitive Procurement Strategy: Exclusive RightsComprehensive Land Claim Agreement: NoVendor Name and Address: EMERGENT BIOSOLUTIONS CANADA INC.155 Innovation DriveWinnipeg ManitobaCanadaR3T5Y3Nature of Requirements: 1. Definition of the requirement Public Services and Procurement Canada intends to establish a Contract with Emergent BioSolutions Inc. for vaccinia immunoglobulin intravenous (Human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus. Canada has a requirement for up to approximately 6,000 vials of VIG (2,000 vials by March 31, 2022).2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that it meets the following requirements:a) The product must have regulatory approval from Health Canada (HC);b) The product be approved by HC with an indication for the treatment and/or modification of the following conditions:i. eczema vaccinatum; ii. progressive vaccinia;iii. severe generalized vaccinia; iv. vaccinia infections in persons with certain skin conditions (such as burns, impetigo, varicella zoster or poison ivy); or in individuals who have eczematous skin lesions because of either the activity or extensi...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Vaccinia Immune Globulin (Vig) (6D024-214840/A) - Canada Tender

The PUBLIC WORKS AND GOVERNMENT SERVICES CANADA, a Government sector organization in Canada, has announced a new tender for Vaccinia Immune Globulin (Vig) (6D024-214840/A). This tender is published on CanadaTenders under CAT Ref No: 60926009 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-12-23.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.